Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Real-world safety and discontinuation patterns of ibrutinib in B-cell malignancies: A 9-year experience from Qatar

Ghasoub Rola, Maria Benkhadra, Anas Hamad, Randa AlOkka, Ruba Yasin Taha, Honar Cherif, Safaa Alazawi, Mohammad Bakir, Shereen Elazzazy

Blood (2025) 146 (Supplement 1): 7128.

https://doi.org/10.1182/blood-2025-7128

Published: 2025

Journal Articles

Tailored prophylaxis in severe hemophilia A: Real-world experience with efanesoctocog alfa

Amna Gameil, Rawan Dawoud, Aliaa Amer, Fareeda Alam, Shehab Mohamed, Hajer Al-Mulla, Fatima Taloozy, Deena Mudawi, Anas Hamad, Honar Charif, Liam Joseph

Blood (2025) 146 (Supplement 1): 6626.

https://doi.org/10.1182/blood-2025-6626

Published: 2025

Journal Articles

Characterizing thrombosis in acute promyelocytic leukemia: Real-world insights from the middle east

Hawraa Shawaylia, Rafal Alshebly, Anil Yousaf, Rola Ghasoub, Dina Soliman, Deena Mudawi, Abdulrahman Al-Mashdali, Mohammed Termanini, Hesham Elsabah, Anas Hamad, Honar Charif, Shehab Mohamed

Blood (2025) 146 (Supplement 1): 6612.

https://doi.org/10.1182/blood-2025-6612

Published: 2025

Journal Articles

Beyond survival in chronic myeloid leukemia: A systematic review of secondary malignancies in the era of tyrosine kinase inhibitors

Ghasoub Rola, Maria Benkhadra, Laila Shafei, Sara Aldali, Layali Bakir, Anas Hamad, Saad Laws, Mohamed Yassin

Blood (2025) 146 (Supplement 1): 5548.

https://doi.org/10.1182/blood-2025-5548

Published: 2025

Journal Articles

Real-world descriptive analysis of the use of bispecific t cell engagers (BiTEs) in the treatment of hematological malignancies in Qatar: A state-wide retrospective cohort study

Rawan Dawoud, Farah Jibril, Maria Benkhadra, Sahar Nasser, Amaal Gulied, Anas Hamad, Honar Charif, Mohamed Yassin, Ruba Yasin Taha, Safaa Alazawi, Hesham Elsabah, Deena Mudawi, Sarah Elkourashy, Shereen Elazzazy

Blood (2025) 146 (Supplement 1): 7264.

https://doi.org/10.1182/blood-2025-7264

Published: 2025

Journal Articles

Real-world assessment of early toxicities, treatment modifications, and outcomes with daratumumab, bortezomib, lenalidomide, and dexamethasone (D-VRd) in multiple myeloma

Hesham Elsabah, Ghasoub Rola, Anas Hamad, Maria Benkhadra, Aya Alasmar, Amaal Gulied, Deena Mudawi, Hawraa Shawaylia, Mohammad Bakir, Honar Cherif

Blood (2025) 146 (Supplement 1): 7508.

https://doi.org/10.1182/blood-2025-7508

Published: 2025

Journal Articles

Caplacizumab as a pre-emptive therapy in thrombotic thrombocytopenic purpura: A proactive strategy to reduce morbidity

Maria Benkhadra, Abdulrahman Al-Mashdali, Sarah Elkourashy, Anas Hamad, Shehab Mohamed, Halima El Omri, Honar Cherif

Blood (2025) 146 (Supplement 1): 6662.

https://doi.org/10.1182/blood-2025-6662

Published: 2025

Journal Articles

Unmasking PNH: Epidemiological and clinical insights from Qatar

Amna Gameil, Suhair El ajez, Omnya Abdalla, Wafa Mohammed, Dina Soliman, Samah Kohla, Aliaa Amer, Yahya Mulikandathil, Ibrahim Ganwo, Anas Hamad, Honar Charif, Feryal Hilmi

Blood (2025) 146 (Supplement 1): 6722.

https://doi.org/10.1182/blood-2025-6722

Published: 2025

Journal Articles

Genomic insights and risk stratification in AML: Findings from a uniquely young national cohort in Qatar (AML-QC)

Amna Gameil, Mahmoud Hailk, Feryal Hilmi, Maria Benkhadra, Wafa Mohammed, Afraa Fadul, Salma Suliman, Farah Jibril, Samah Kohla, Mohamed Ibrahim, LAYLA MOHAMED, Amaal Gulied, Muna Al Zeyara, Hesham Elsabah, Amal Aly, Anas Hamad, Kalpana Singh, Honar Charif

Blood (2025) 146 (Supplement 1): 6928.

https://doi.org/10.1182/blood-2025-6928

Published: 2025

Journal Articles

From crisis to cure? thirteen years of real-world trends in acute promyelocytic leukemia outcomes in Qatar

Ghasoub Rola, Hesham Elsabah, Anas Hamad, Nabeel Qasem, Hawraa Shawaylia, Feryal Hilmi, Halima El Omri, Rajvir Singh, Shehab Mohamed, Abdulrahman Al-Mashdali, Anil Yousaf, Honar Cherif

Blood (2025) 146 (Supplement 1): 6926.

https://doi.org/10.1182/blood-2025-6926

Published: 2025

Journal Articles

Healthcare Providers' knowledge and attitudes toward venous thromboembolism prophylaxis in multiple myeloma: A cross-sectional survey

Ghasoub Rola, Maria Benkhadra, Anas Hamad, Mohammad Bakir, Hesham Elsabah, Layali Bakir, Rajvir Singh, Honar Cherif, Shereen Elazzazy

Blood (2025) 146 (Supplement 1): 6348.

https://doi.org/10.1182/blood-2025-6348

Published: 2025

Journal Articles

Budget impact analysis of rituximab biosimilar in patients with haematological cancers in Qatar

Laila Shafei, Amir Nounou, Mohamed Yassin, Anas Hamad

Blood (2025) 146 (Supplement 1): 7941.

https://doi.org/10.1182/blood-2025-7941

Published: 2025

Journal Articles

Thrombotic events as initial presentation of acute promyelocytic leukemia (APL): A literature-based review of patient-level data

Hawraa Shawaylia, Noor Moustafa, Mohamad Dulli, Anil Yousaf, Ghasoub Rola, Dina Soliman, Deena Mudawi, Abdulrahman Al-Mashdali, Mohammed Termanini, fatma shwaylia, Hesham Elsabah, Anas Hamad, Honar Charif, Shehab Fareed

Blood (2025) 146 (Supplement 1): 6894.

https://doi.org/10.1182/blood-2025-6894

Published: 2025

Journal Articles

Epidemiologic and Clinical Patterns of Lymphoma in Qatar 2013-2017: A Population-Based Cohort Study

Ahmed A Adel, Aimilia Exarchakou, Anas Hamad, Ruba Yasin, Hafedh Ghazouani, Mohamed A Yassin

Blood (2021) 138 (Supplement 1): 4584.

https://doi.org/10.1182/blood-2021-144637

Published: 2021

Journal Articles

L-Glutamine and Crizanlizumab for Adults with Sickle Cell Disease (SCD) in Qatar: A Cost Effectiveness Analysis

Ahmed A Adel, Dina Abushanab, Anas Hamad, Daoud Al-Badriyeh, Mohamed A Yassin

Blood (2021) 138 (Supplement 1): 4945.

https://doi.org/10.1182/blood-2021-144636

Published: 2021

Journal Articles

Efficacy and Cost Effectiveness of Intravenous Ferric Carboxymaltose Versus Iron Sucrose in Adult Patients with Iron Deficiency Anemia

Ahmed Basha, BSC, Mohamed Izham, PhD, Anas Hamad, PhD, Prem Chandra, PhD, Nabil E Omar, PharmD, Mohammad Abdul-Jaber Abdulla, MD, Mahmood B Aldapt, MD, Radwa M Hussein, BSC, Ahmed Mahfouz, MSc, Ahmed A Adel, BSC, Hawraa M Shwaylia, MD, Yeslem Mohamed Aly Ekeibed, MBBS, MD, Rami AbuMousa, MSc (pharm), Mohamed A Yassin, MBBS, MSc

Blood (2020) 136 (Supplement 1): 19–20.

https://doi.org/10.1182/blood-2020-134537

Published: 2020

Journal Articles

The Impact of Ethnicity on the Response to Eltrombopag in Patients with Immune Thrombocytopenia (ITP) in Qatar: A Single Institution Experience

Mohamed A Yassin, MBBS, MSc, Aya Alasmar, BSC, Rola Ghasoub, BSC, Omer Ismail, MD CABM, Abdulqadir Jeprel Nashwan, BSN, MSN, Firdous Ghori, MBBS CABM, Deena Sideeg, MBBS MRCP, Radwa M Hussein, BSC, Randa Al -Okka, BSC, Prem Chandra, PhD, Anas Hamad, PhD, Ashraf Tawfiq Soliman, MDPhD

Blood (2020) 136 (Supplement 1): 7–8.

https://doi.org/10.1182/blood-2020-134416

Published: 2020

Journal Articles

Effects of Ramadan Fasting on Patients with Immune Thrombocytopenia (ITP) Receiving Eltrombopag

Mohamed A Yassin, MBBS, MSc, Aya Alasmar, BSC, Prem Chandra, PhD, Omer Ismail, MD CABM, Abdulqadir Jeprel Nashwan, BSN, MSN, Deena Sideeg, MBBS MRCP, Firdous Ghori, MBBS CABM, Anas Hamad, PhD, Rola Ghasoub, BSC

Blood (2020) 136 (Supplement 1): 8–9.

https://doi.org/10.1182/blood-2020-134421

Published: 2020

Journal Articles

Dasatinib and Nilotinib As Upfront Therapy for Chronic-Phase Chronic Myeloid Leukemia (CML-CP) in Qatar: A Cost Effectiveness Analysis (CEA)

Ahmad M Adel, MSc, Dina Abushanab, MSc, Anas Hamad, PhD, Mohammad Abdul-Jaber Abdulla, MD, Mohamed A Yassin, MBBS, MSc

Blood (2019) 134 (Supplement_1): 5850.

https://doi.org/10.1182/blood-2019-121833

Published: 2019

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Real-world safety and discontinuation patterns of ibrutinib in B-cell malignancies: A 9-year experience from Qatar

Tailored prophylaxis in severe hemophilia A: Real-world experience with efanesoctocog alfa

Characterizing thrombosis in acute promyelocytic leukemia: Real-world insights from the middle east

Beyond survival in chronic myeloid leukemia: A systematic review of secondary malignancies in the era of tyrosine kinase inhibitors

Real-world descriptive analysis of the use of bispecific t cell engagers (BiTEs) in the treatment of hematological malignancies in Qatar: A state-wide retrospective cohort study

Real-world assessment of early toxicities, treatment modifications, and outcomes with daratumumab, bortezomib, lenalidomide, and dexamethasone (D-VRd) in multiple myeloma

Caplacizumab as a pre-emptive therapy in thrombotic thrombocytopenic purpura: A proactive strategy to reduce morbidity

Unmasking PNH: Epidemiological and clinical insights from Qatar

Genomic insights and risk stratification in AML: Findings from a uniquely young national cohort in Qatar (AML-QC)

From crisis to cure? thirteen years of real-world trends in acute promyelocytic leukemia outcomes in Qatar

Healthcare Providers' knowledge and attitudes toward venous thromboembolism prophylaxis in multiple myeloma: A cross-sectional survey

Budget impact analysis of rituximab biosimilar in patients with haematological cancers in Qatar

Thrombotic events as initial presentation of acute promyelocytic leukemia (APL): A literature-based review of patient-level data

Epidemiologic and Clinical Patterns of Lymphoma in Qatar 2013-2017: A Population-Based Cohort Study

L-Glutamine and Crizanlizumab for Adults with Sickle Cell Disease (SCD) in Qatar: A Cost Effectiveness Analysis

Efficacy and Cost Effectiveness of Intravenous Ferric Carboxymaltose Versus Iron Sucrose in Adult Patients with Iron Deficiency Anemia

The Impact of Ethnicity on the Response to Eltrombopag in Patients with Immune Thrombocytopenia (ITP) in Qatar: A Single Institution Experience

Effects of Ramadan Fasting on Patients with Immune Thrombocytopenia (ITP) Receiving Eltrombopag

Dasatinib and Nilotinib As Upfront Therapy for Chronic-Phase Chronic Myeloid Leukemia (CML-CP) in Qatar: A Cost Effectiveness Analysis (CEA)

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only